Search
- Apr 18
Pear VC's Eddie Eltoukhy describes investing in life sciences early at the seed and pre-seed stages
Eddie Eltoukhy explains the unique role that seed investors have in helping entrepreneurs succeed, he lists some areas of science of...
- Apr 11
Wedbush's Robert Driscoll joins BiotechTV for Analyst Thursdays
He discusses Vertex's acquisition of Alpine Immune Science, Bloomberg's reporting on Janux, and more.
- Apr 9
TCGX's Chen Yu describes the benefits of being able to focus on public and privates during different stages of the biotech cycle
Dr. Yu describes how TCGX's structure and nimbleness has led to investments in number companies that have been acquired over the last year.
- Apr 3
Nobel laureate Carolyn Bertozzi and Acepodia Co-Founder Sonny Hsiao on the science of antibody-cell conjugates
Dr. Bertozzi and Dr. Hsiao describe how Acepodia is leveraging biorthogonal chemistry to conjugate antibodies to allogeneic γδ2 T cells.
- Mar 28
BTIG's Thomas Shrader joins BiotechTV for Analyst Thursdays from San Francisco
Thomas Shrader shares his thoughts on biotech and comments on companies he covers.
- Mar 21
William Blair's Andy Hsieh returns to Analyst Thursdays to talk radiopharma buyouts, obesity and more
Andy Hsieh gives his take on the radiopharmaceutical space, Viking’s obesity data, Pyxis Oncology, Cardiff Oncology, Fibrogen.